Jean-Baptiste Thibert: Protecting Fundamental Human Rights to Improve Patient Access and Donor Health
Jean-Baptiste Thibert, Medical and Biology Director at EFS, shared a post on LinkedIn recent article he and his colleagues co-authored, adding:
“Excited to share our latest collaborative work on protecting fundamental human rights, thereby improving both patient access to plasma-derived therapies and donor health protection.
Patient access to plasma-derived medicinal products and blood donor protection are challenges that are currently hard to meet and often presented like mutually exclusive choices.
We show how advantageous it could be to reposition the fundamental right to health protection as an input parameter for decisions on the transfusion and plasma supply chain.
Placing both patients and donors under the umbrella of fundamental human rights allows to act not as if a choice has to be made between patients and donors, but in ways that protect them both.”
Katja van den Hurk, Head of Donor Studies and Senior Epidemiologist/Principal Investigator at Sanquin, Professor of Donor Health at University of Amsterdam, shared this post on LinkedIn, adding:
“Happy to see this collaborative work published!
Our paper discusses how placing patients and donors under the same human-rights framework can help address challenges in plasma supply; supporting both access to plasma-derived medicinal products and donor health protection.”
Title: Protection of fundamental human rights by improving patient access to plasma-derived therapies and donor health protection
Authors: Jean-Baptiste Thibert, Leni von Bonsdorff, Jean-Philippe Plançon, Vincenzo de Angelis, Cynthia So-Osman, Christian Erikstrup, Pierre Tiberghien, Katja van den Hurk
Read the Full Article on Vox Sanguinis
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy